Topic

Kenneth Getz is a senior research fellow at the Tufts Center for the Study of Drug Development.

Articles

New benchmarks uncover a maturing and globally-shifting market.

Tracking Change in the Global Investigative Site Landscape

Mary Costello, Head of Site and Investigator Networks at Medable, and Stephanie Abbott, Clinical Research Director at Western Washington Medical Group, discuss the changing landscape of decentralized clinical trials.

Amidst DCTs, Will Sites be Cut From Clinical Research?

Has technology taken the industry too far?

Sites Still Necessary for Decentralized Trials

New support models range from flexible software platforms, IROs, and DROs.

The Evolution of Site Selection

InterveXion CEO Keith Ward and Andrew Schafer, vice president of strategy for Biospatial discuss the details of a study which utilizes EMS data to identify sites for a Phase II clinical trial.

Utilization of EMS Data in Site Selection

Industry-wide unity paves path for preparedness.

“Warm and Ready” Clinical Trial Sites

Bringing clinical trials to patients’ homes can address existing site-based challenges.

Patient-Tested Practices for In-Home Trials

Lessons learned during the pandemic from University of Louisville.

Accelerating Research Site Operations

While it's important to note that there are areas where the industry can improve, there are unique opportunities of improvement for specific types of sites and the number of studies conducted there. 

Investigative Sites